论文部分内容阅读
本文总结我院自1954年12月至1981年底用根治术治疗胃贲门癌440例的经验。本组的区域淋巴结转移率为70％。全组病人的5年生存率为18.5％,10年生存率为10.7％。 Ⅰ期贲门癌根治术Ⅰ式与根治术Ⅱ式的疗效相似。Ⅱ期贲门癌无论区域淋巴结有否转移,Ⅱ式的疗效皆优于Ⅰ式,但统计学处理并无显著差别。Ⅲ期淋巴结阴性患者,Ⅱ式疗效虽优于Ⅰ式,但无统计学意义;惟淋巴结阳性患者,Ⅱ式疗效确实优于Ⅰ式(P<0.05) 胃贲门癌的发病率约占胃癌的20％,其症状同于食管下端癌,某些早期贲门癌在临床上易与食管下端癌混淆,只能在手术标本上大致判断其原发部位。目前,手术治疗仍是治疗胃癌的治愈性手段,而化疗仅能收到一定的姑息效果。今将我院用两种根治术治疗贲门癌的结果报道于下。
This article summarizes the experience of 440 cases of gastric cardia cancer treated by radical surgery in our hospital from December 1954 to the end of 1981. The regional lymph node metastasis rate in this group was 70%. The 5-year survival rate for the whole group was 18.5%, and the 10-year survival rate was 10.7%. The efficacy of I-type radical gastrectomy with type I and radical mastectomy II is similar. Stage II cardiac cancer regardless of regional lymph node metastasis, II type of efficacy are better than I type, but there is no statistically significant difference. In phase III lymph node negative patients, type II efficacy was better than type I, but it was not statistically significant. However, in patients with positive lymph nodes, type II efficacy was indeed better than type I (P<0.05). The incidence of gastric cardia cancer accounts for about 20 of gastric cancer %, its symptoms are the same with the lower esophageal cancer, some of the early cardiac cancer is easily confused with the lower esophageal cancer, can only roughly determine its primary site in surgical specimens. At present, surgical treatment is still a cure for gastric cancer, and chemotherapy can only receive certain palliative effects. The results of the treatment of cardiac cancer with two types of radical surgery in our hospital are reported below.